{"nct_id":"NCT02082210","title":"A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2014-03-07","start_date_type":"ACTUAL","primary_completion_date":"2017-12-05","primary_completion_date_type":"ACTUAL","completion_date":"2018-01-24","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["LLY"]}